Commonwealth Bank of Australia lifted its position in shares of HCP, Inc. (NYSE:HCP) by 3.3% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 68,327 shares of the real estate investment trust’s stock after acquiring an additional 2,200 shares during the period. Commonwealth Bank of Australia’s holdings in HCP were worth $1,793,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in HCP. Amalgamated Bank raised its holdings in HCP by 3.6% in the 2nd quarter. Amalgamated Bank now owns 60,479 shares of the real estate investment trust’s stock worth $1,562,000 after purchasing an additional 2,084 shares during the period. Cornerstone Wealth Management LLC bought a new position in HCP in the 2nd quarter worth $1,542,000. Whittier Trust Co. raised its holdings in HCP by 78.4% in the 2nd quarter. Whittier Trust Co. now owns 9,770 shares of the real estate investment trust’s stock worth $404,000 after purchasing an additional 4,293 shares during the period. Janney Montgomery Scott LLC raised its holdings in HCP by 7.7% in the 2nd quarter. Janney Montgomery Scott LLC now owns 257,230 shares of the real estate investment trust’s stock worth $6,642,000 after purchasing an additional 18,408 shares during the period. Finally, Hedeker Wealth LLC bought a new position in HCP in the 2nd quarter worth $387,000. Institutional investors and hedge funds own 89.32% of the company’s stock.

Shares of NYSE:HCP opened at $28.86 on Thursday. The company has a quick ratio of 0.48, a current ratio of 0.48 and a debt-to-equity ratio of 1.21. HCP, Inc. has a 12 month low of $21.48 and a 12 month high of $29.32. The stock has a market capitalization of $13.60 billion, a P/E ratio of 14.80, a price-to-earnings-growth ratio of 7.29 and a beta of 0.16.

HCP (NYSE:HCP) last announced its quarterly earnings results on Wednesday, October 31st. The real estate investment trust reported $0.21 EPS for the quarter, beating the Zacks’ consensus estimate of $0.11 by $0.10. HCP had a net margin of 9.16% and a return on equity of 3.06%. The firm had revenue of $456.00 million during the quarter, compared to the consensus estimate of $456.59 million. During the same quarter last year, the firm earned $0.48 EPS. The firm’s revenue for the quarter was up .4% compared to the same quarter last year. On average, sell-side analysts forecast that HCP, Inc. will post 1.82 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 20th. Investors of record on Monday, November 5th were issued a $0.37 dividend. This represents a $1.48 dividend on an annualized basis and a dividend yield of 5.13%. The ex-dividend date was Friday, November 2nd. HCP’s payout ratio is 75.90%.

HCP has been the subject of a number of analyst reports. Zacks Investment Research lowered HCP from a “hold” rating to a “sell” rating in a research note on Tuesday, July 31st. Stifel Nicolaus set a $28.00 price target on HCP and gave the stock a “buy” rating in a research note on Friday, August 3rd. Cantor Fitzgerald initiated coverage on HCP in a research note on Tuesday, August 7th. They issued a “neutral” rating and a $28.00 price target for the company. Robert W. Baird increased their price target on HCP from $24.00 to $26.00 and gave the stock a “neutral” rating in a research note on Thursday, August 9th. Finally, Mizuho reiterated a “buy” rating and issued a $29.00 price target on shares of HCP in a research note on Monday, August 13th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and six have given a buy rating to the company’s stock. HCP has a consensus rating of “Hold” and a consensus price target of $26.75.

WARNING: This news story was first reported by Daily Political and is the property of of Daily Political. If you are reading this news story on another site, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The correct version of this news story can be viewed at https://www.dailypolitical.com/2018/11/22/commonwealth-bank-of-australia-acquires-2200-shares-of-hcp-inc-hcp.html.

HCP Company Profile

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

Featured Article: Insider Trading – What You Need to Know

Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP, Inc. (NYSE:HCP).

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.